论文部分内容阅读
子宫内膜癌是美国最为常见的妇科肿瘤,每年新增病例43 470例,约占女性肿瘤的6%[1]。大部分的病例在早期即被确诊,可通过手术治愈。局部发病的患者有96%的5年生存率,而区域疾病患者和转移患者则下降至67%和17%。基于国际妇产科联盟(FIGO)的标准,子宫内膜癌采用手术分期[2-3]。尽管有这些准则,子宫内膜癌的全面分期手术的实施仍存在争议。一、从临床分期到手术分期的转变1988年之前,子宫内膜癌的FIGO分期是基于临床的[2]。子宫内膜癌临床Ⅰ期定义为癌灶仅局限
Endometrial cancer is the most common gynecological cancer in the United States, with an annual increase of 43 470 cases, accounting for about 6% of female tumors [1]. The majority of cases are diagnosed early and can be surgically cured. Patients with localized disease have a 5-year survival rate of 96%, whereas those with regional disease and metastases fall to 67% and 17%. Based on the International Association of Obstetrics and Gynecology (FIGO) criteria, endometrial cancer using surgical staging [2-3]. Despite these guidelines, the implementation of a comprehensive staging procedure for endometrial cancer remains controversial. First, the change from clinical staging to surgical staging Before 1988, the FIGO staging of endometrial cancer was based on clinical [2]. Endometrial cancer clinical stage Ⅰ is defined as only localized cancer